<DOC>
	<DOCNO>NCT01476111</DOCNO>
	<brief_summary>This study examine specific biomarkers primary invasive breast cancer explore correlation patient outcome follow standard neoadjuvant treatment .</brief_summary>
	<brief_title>Evaluation Specific Biomarkers Primary Invasive Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>The patient 18 year age old time consent . The patient provide pretreatment tumor sample WT1 expression screen gene expression profile context NCT01220128 study . The patient histologically cytologically confirm primary invasive breast cancer . The patient provide write informed consent new information new material provide Sponsor . The patient plan receive , receive receive standard and/or investigational therapy breast cancer . The patient plan receive , receive receive standard and/or investigational therapy breast cancer .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>tumor antigen</keyword>
	<keyword>observational</keyword>
	<keyword>breast cancer</keyword>
	<keyword>biomarkers</keyword>
	<keyword>Neoadjuvant</keyword>
</DOC>